Dr. Dina C. Titova, MD

Dr. Titova practices at MultiCare Tacoma General Hospital in Tacoma, Washington, part of MultiCare Health System.

Dr. Titova's NPI, 1861549651, was assigned on January 4, 2007. Dr. Titova holds Washington license MD00048351.

Dr. Titova's primary practice is MultiCare Tacoma General Hospital, at 315 S Mlk Jr Way, Tacoma, WA 98405 in Pierce County. The practice phone is (253) 403-1000.

Dr. Titova's primary practice is MultiCare Tacoma General Hospital in Tacoma, Washington, part of MultiCare Health System. Dr. Titova is also affiliated with MultiCare Good Samaritan Hospital. The medical group on file is MultiCare Indigo Urgent Care, Spokane, Newport Hwy. Dmand AI also links Dr. Titova to 2 more hospitals, 1 behavioral health center, 1 group practice or clinic and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Titova practices, 7 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Titova's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Titova is licensed in Washington.

CMS data shows 1,185 Medicare services from Dr. Titova across 5 procedure codes in 2024, for 278 Medicare patients. Medicare paid $59,219 for them. Every service was in an office.

CMS counts 278 Medicare patients who saw Dr. Titova in 2024. The largest group is 65 to 74, with 126 patients. 75% of them have arthritis, and 72% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Titova's median patient age at 70, with 79% women.

In 2024, Dr. Titova wrote 2,925 Medicare Part D claims for 481 patients. 81% of them were for generic drugs. CMS names the drug for 2,750 of them, across 38 drugs with 11 or more claims each, at $1,745,632 in total drug cost. In 2023, CMS named 2,520 claims across 33 drugs.

Dr. Titova accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Titova as offering telehealth.

CMS Open Payments shows 140 general payments to Dr. Titova from 18 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 54% of the total. Horizon Pharma plc paid the most, $3,128.